Overview

Efficacy/Safety of Cilnidipine Plus Valsartan Versus Valsartan in Patients With Hypertension

Status:
Completed
Trial end date:
2016-09-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate of efficacy and safety of cilinidipine plus valsartan and valsartan alone in patients with essential hypertension inadequately controlled on valsartan monotherapy
Phase:
Phase 3
Details
Lead Sponsor:
IlDong Pharmaceutical Co Ltd
Treatments:
Cilnidipine
Valsartan